S&CO Inc. Has $1.99 Million Holdings in Humana Inc. $HUM

S&CO Inc. cut its position in shares of Humana Inc. (NYSE:HUM) by 64.1% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 8,138 shares of the insurance provider’s stock after selling 14,558 shares during the quarter. S&CO Inc.’s holdings in Humana were worth $1,989,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Cary Street Partners Investment Advisory LLC lifted its position in shares of Humana by 63.9% in the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock valued at $31,000 after acquiring an additional 46 shares in the last quarter. Zions Bancorporation National Association UT acquired a new stake in Humana during the 1st quarter valued at $37,000. CVA Family Office LLC lifted its holdings in shares of Humana by 63.4% in the second quarter. CVA Family Office LLC now owns 219 shares of the insurance provider’s stock valued at $54,000 after purchasing an additional 85 shares in the last quarter. Ransom Advisory Ltd acquired a new stake in shares of Humana in the first quarter worth $66,000. Finally, Transamerica Financial Advisors LLC grew its holdings in shares of Humana by 1,027.6% during the first quarter. Transamerica Financial Advisors LLC now owns 327 shares of the insurance provider’s stock valued at $87,000 after buying an additional 298 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on HUM shares. Wells Fargo & Company increased their price objective on Humana from $344.00 to $347.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Guggenheim restated a “buy” rating on shares of Humana in a report on Friday, October 3rd. Mizuho boosted their price objective on shares of Humana from $300.00 to $345.00 and gave the company an “outperform” rating in a research report on Thursday, October 9th. Wolfe Research increased their target price on shares of Humana from $283.00 to $313.00 and gave the stock an “outperform” rating in a research report on Monday, October 6th. Finally, Evercore ISI assumed coverage on shares of Humana in a report on Monday, September 22nd. They set an “in-line” rating and a $295.00 price target on the stock. Eight research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, Humana has an average rating of “Hold” and a consensus price target of $299.22.

Humana Price Performance

NYSE HUM opened at $251.46 on Monday. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69. The stock has a market capitalization of $30.24 billion, a PE ratio of 19.30, a price-to-earnings-growth ratio of 1.71 and a beta of 0.42. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35. The company has a 50 day moving average price of $278.04 and a two-hundred day moving average price of $258.86.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, beating analysts’ consensus estimates of $2.95 by $0.29. Humana had a net margin of 1.28% and a return on equity of 13.67%. The business had revenue of $32.65 billion for the quarter, compared to the consensus estimate of $31.99 billion. During the same quarter last year, the firm earned $4.16 EPS. Humana’s revenue for the quarter was up 11.1% on a year-over-year basis. As a group, equities analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.4%. Humana’s dividend payout ratio is currently 33.18%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.